Cargando…
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
BACKGROUND: In insulin-treated patients with type 2 diabetes mellitus (T2DM), glycemic control is usually suboptimal. METHODS: This study compared the risks of mortality and cardiovascular events in insulin-treated patients adding or not adding alpha-glucosidase inhibitors (AGIs). RESULTS: This coho...
Autores principales: | Yen, Fu-Shun, Wei, James Cheng-Chung, Lin, Mei-Chen, Hsu, Chih-Cheng, Hwu, Chii-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890630/ https://www.ncbi.nlm.nih.gov/pubmed/33602190 http://dx.doi.org/10.1186/s12902-021-00690-0 |
Ejemplares similares
-
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022) -
All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2019) -
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2021) -
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020) -
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021)